FILTRIX™ sterile film evaporation system, the 'exclusive key' for peptide commercialization!

洁维1.png

In 2025, the global peptide industry scored wins on two fronts: the therapeutic drug market reached 320.42 billion yuan (expected to grow to 563.47 billion yuan by 2032, with a compound annual growth rate of 8.4%), mainly driven by the GLP-1 sector, with semaglutide and tirzepatide alone hitting over $31.4 billion in sales in the first half of the year; at the same time, the bioactive peptide market in the medical aesthetics and consumer sector reached $26.6 billion (expected to grow to $59.4 billion by 2034), with a 12.5% CAGR that’s even higher than the pharmaceutical side, showing even stronger potential.

Production capacity is expanding across both major sectors, but the whole industry is generally facing the same mass production challenge：The small-scale lab tests were of excellent quality, but large-scale production is unstable, impure, and not sterile.

洁维2.png

As a highly active functional ingredient, polypeptides are very sensitive to temperature and oxidation due to their molecular structure. Traditional kettle-type and conventional evaporation equipment can only achieve basic concentration. However, in large-scale production, they show systemic problems like low heat transfer efficiency, process scale-up distortions, and uncontrolled biological load, which have become key bottlenecks limiting the commercialization of high-end polypeptides.

Industry consensus shows that general equipment can't handle the tough properties of peptides, so mass production has to rely on specially customized gear. Sterile film evaporation system，It's tailor-made for the two main tracks of weight loss and medical aesthetics, offering a seamless one-stop solution from small-scale process development → pilot-scale validation → commercial continuous production. Compared to regular evaporators that skirt regulations or ultrafiltration equipment, which is costly and not very solvent-resistant, the thin-film evaporation system features a fully enclosed sterile design with precise heat zone control, achieving a technological leap from 'basic concentration' to 'compliant mass production'.

Say goodbye to general-purpose equipment | Mass production of peptides requires specialized process equipment

Core consensus in the peptide industry: Industrializing peptides means the processes match specialized equipment, not the equipment adapting to general processes.

Traditional equipment is naturally unsuitable for peptide production: long high-temperature cooking causes excessive degradation, the lack of a scraping structure leads to carbonization loss, and the open design can't meet sterile compliance, so it can only achieve 'rough mass production'.

A sterile film evaporation system, customized in five special areas—structure, temperature control, film formation, sterility, and automation—based on the characteristics of peptides in two major tracks, truly achieving high-purity, sterile, stable, and scalable commercial production of peptides.

Track-Specific Solutions | Jiewe Biology FILTRIXT Sterile Thin-Film Evaporation System

FILTRIX series of sterile film evaporation systems use a standardized modular design, and they can also provide flexible customized solutions based on the user's process characteristics, material properties, and plant hardware conditions, fully supporting applications from R&D and pilot testing to large-scale production.

Seven core advantages perfectly match high-end peptide production:

✅ Hygienic Design

✅ Gentle Handling

✅ High Efficiency Concentration

✅ Continuous Production

✅ Standardized & Customized

✅ Compliance & Traceability

✅ Full Lifecycle Service

Competition in the peptide industry has moved from the early stages of molecule discovery to the later stages of industrialization capabilities. Whoever can first break through the bottleneck of 'it works in the lab but not in mass production' will gain an advantage in this golden race.

The 'exclusive key' to unlocking this bottleneck is the FILTRIX™ series of sterile thin-film evaporation systems.

Brand announcement preview｜Coming soon

Jiewelbio will officially announce on July 30 — the complete FILTRIX™ sterile membrane evaporation system solution.

By then, the complete process parameters, mass production test data, GMP compliance system, and track-customized solutions will be fully disclosed to help companies overcome mass production bottlenecks, seize track advantages, and achieve compliant large-scale upgrades.

Keywords:

Analysis of Inosine, referring to the Chinese Pharmacopoeia (2025 edition), Part II

Determination of Hu Huanglian content, referring to the Chinese Pharmacopoeia (2025 edition), Part I